Tagged with research,

Malaysia Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination.   We have a population of 32 million which represents a third of the world’s genomics Dr Akhmal Yusof, CRM Dr…

Malysia Dr Goh Pik Pin, director of the Clinical Research Centre (CRC), and Dr Salina Abd Aziz, consultant psychiatrist and chairperson, MOH Medical Research Ethics Committee, and head, CRC Hospital Kuala Lumpur, highlight the main improvements of the CRC as well as the clinical research environment in Malaysia since 2014. Dr…

France David Kimelfeld, president of Lyon Métropole, speaks out about his plans for the region in terms of industrial innovation and sustainability, describing how Lyon’s historical roots would represent and enhance its future development.   Lyon has become recognized nationally and internationally as possessing all the requisite qualities to host high…

Korea Jia Liu, CEO of DreamCIS, a Korean CRO, part of the Chinese company Tigermed, talks about her vision for DreamCIS to be “the CRO everybody wants to work with”. Liu assesses the changing environment for clinical research in Korea and offers her view on the successes and scope for improvement…

Malaysia Dr Hassan Yaakob of Healwell Pharmaceutical Co. Ltd., discusses the company’s rejuvenating and anti-ageing products, made from a polypeptide derived from sea cucumber. He also gives insights into the changing consumer preferences for his products, and the need to move marketing online in the digital world.   Our products sit between…

France Jean Monin, general manager of Amgen France, discusses the challenges of bringing products to market in France and what is needed to better promote biosimilars. He also talks about his main achievements since joining the company six years ago.   We have been active in France for nearly 30 years…

Malaysia Dr. Fadzilah Kamaludin, the director of the Institute for Medical Research (IMR) in Malaysia, highlights the important role of the IMR, as a public organization, to help the research in key therapeutic areas and its ambitions to help commercialize solutions that will benefit patients in Malaysia and around the world.…

Malaysia Ewe Kheng Huat, executive director of PhAMA, the Malaysian association for innovative companies, describes the current market environment for innovative medicines in Malaysia, from the difficulties to enter the Malaysian market to the great opportunities the country can offer in terms of clinical research and shared services.   We believe…

France Stewart Cole, president of Institut Pasteur, speaks out about his aspirations as the first foreign president of the institute and the main themes of the new strategic plan.   Brexit is a great tragedy for everyone and it is a concerning development for Britain and Europe in my opinion. It…

Malaysia Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research future and explains what makes Malaysia such a worthwhile location to invest in international clinical research.   If we consider…

Spain Following Bayer’s acquisition of Monsanto, a US agriculture giant, the company is facing a new era in which its pharmaceutical arm is still a highly strategic part. Bernardo Kanahuati, Bayer’s CEO for Iberia, highlights the importance of Spain’s manufacturing and R&D for Bayer International, as well as his strategy to…

France Dr. Catherine Jessus, Director of the INSB (Institute of Biological Sciences), the largest branch of the CNRS (National Center for Scientific Research) in France, discusses the strengths and weaknesses of the French biological research ecosystem, public-private partnerships, and post-Brexit France.  The CNRS has activity in nearly every field of science…